MXPA02009257A - Metodos y composiciones para elucidar perfiles de expresion de proteina en celulas. - Google Patents

Metodos y composiciones para elucidar perfiles de expresion de proteina en celulas.

Info

Publication number
MXPA02009257A
MXPA02009257A MXPA02009257A MXPA02009257A MXPA02009257A MX PA02009257 A MXPA02009257 A MX PA02009257A MX PA02009257 A MXPA02009257 A MX PA02009257A MX PA02009257 A MXPA02009257 A MX PA02009257A MX PA02009257 A MXPA02009257 A MX PA02009257A
Authority
MX
Mexico
Prior art keywords
compositions
methods
protein expression
cells
expression profiles
Prior art date
Application number
MXPA02009257A
Other languages
English (en)
Inventor
Charles J Link
Original Assignee
Newlink Genetics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newlink Genetics filed Critical Newlink Genetics
Publication of MXPA02009257A publication Critical patent/MXPA02009257A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion se refiere generalmente a metodos y composiciones para la identificacion de patrones de expresion de proteinas diferenciales y concomitantemente las regiones geneticas activas que estan directamente o indirectamente involucradas en diferentes tipos de tejidos, estados afectivos u otras diferencias celulares deseables para diagnostico o para objetivos para terapia de farmaco.
MXPA02009257A 2000-03-20 2001-03-19 Metodos y composiciones para elucidar perfiles de expresion de proteina en celulas. MXPA02009257A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19067800P 2000-03-20 2000-03-20
PCT/US2001/008770 WO2001070948A2 (en) 2000-03-20 2001-03-19 Methods and compositions for elucidating protein expression profiles in cells

Publications (1)

Publication Number Publication Date
MXPA02009257A true MXPA02009257A (es) 2004-04-05

Family

ID=22702326

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02009257A MXPA02009257A (es) 2000-03-20 2001-03-19 Metodos y composiciones para elucidar perfiles de expresion de proteina en celulas.

Country Status (8)

Country Link
EP (1) EP1268767B1 (es)
JP (1) JP2003527855A (es)
AT (1) ATE312173T1 (es)
AU (1) AU2001249267A1 (es)
CA (1) CA2403567A1 (es)
DE (1) DE60115622T2 (es)
MX (1) MXPA02009257A (es)
WO (1) WO2001070948A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1425416A4 (en) * 2001-08-24 2005-07-20 Health Research Inc HIGH PERFORMANCE SYSTEM FOR THE IDENTIFICATION OF SEQUENCE LABELS
US20060094059A1 (en) * 2004-09-22 2006-05-04 Odyssey Thera, Inc. Methods for identifying new drug leads and new therapeutic uses for known drugs
CN106951732B (zh) 2010-05-25 2020-03-10 加利福尼亚大学董事会 基于计算机的基因组序列分析系统
US9646134B2 (en) * 2010-05-25 2017-05-09 The Regents Of The University Of California Bambam: parallel comparative analysis of high-throughput sequencing data
CN113501861A (zh) * 2021-08-01 2021-10-15 青海瑞肽生物科技有限公司 一种高分辨质谱筛选牦牛胶原蛋白特征片段的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364783A (en) * 1990-05-14 1994-11-15 Massachusetts Institute Of Technology Retrovirus promoter-trap vectors
US5434065A (en) * 1993-05-06 1995-07-18 President And Fellows Of Harvard College In vivo selection of microbial virulence genes
US5922601A (en) * 1995-01-19 1999-07-13 Biotransplant, Inc. High efficiency gene trap selection of regulated genetic loci
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US6207371B1 (en) * 1996-10-04 2001-03-27 Lexicon Genetics Incorporated Indexed library of cells containing genomic modifications and methods of making and utilizing the same
US5994077A (en) * 1997-01-31 1999-11-30 The Board Of Trustees Of The Leland Stanford Junior University Flourescence-based isolation of differentially induced genes
WO1998053319A2 (en) * 1997-05-21 1998-11-26 The Johns Hopkins University Gene expression profiles in normal and cancer cells
DK1066392T3 (da) * 1998-03-27 2008-08-25 Lexicon Pharmaceuticals Inc Vektorer til genmutagenese og gen-discovery
AU3917600A (en) * 1999-03-25 2000-10-09 Massachusetts Institute Of Technology Retroviral vectors and methods for production and use thereof

Also Published As

Publication number Publication date
EP1268767B1 (en) 2005-12-07
DE60115622D1 (de) 2006-01-12
DE60115622T2 (de) 2006-06-22
JP2003527855A (ja) 2003-09-24
EP1268767A2 (en) 2003-01-02
ATE312173T1 (de) 2005-12-15
AU2001249267A1 (en) 2001-10-03
CA2403567A1 (en) 2001-09-27
WO2001070948A9 (en) 2002-12-19
WO2001070948A2 (en) 2001-09-27
WO2001070948A3 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
MY127369A (en) Quinazoline derivatives
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
MY129809A (en) Quinazoline derivatives
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
WO2001078652A3 (en) Methods for drug discovery, disease treatment, and diagnosis using metabolomics
MY143795A (en) Tetrahydropyridoindole derivatives
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
NZ543661A (en) Pyrazolo-quinazoline derivatives having antitumor activity and process for their preparation
MXPA06000302A (es) Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
SG166672A1 (en) Methods of down regulating target gene expression in vivo by introduction of interfering rna
HK1075450A1 (en) heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine
HK1063185A1 (en) Quinoline derivatives and their use as tyrosine kinase inhibitors
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
WO2003017939A3 (en) Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
TNSN04034A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
MXPA02009257A (es) Metodos y composiciones para elucidar perfiles de expresion de proteina en celulas.
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
PL357999A1 (en) Lhrh-antagonists, production and use thereof as medicament
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen

Legal Events

Date Code Title Description
FG Grant or registration